These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21033491)

  • 1. [Medical management of chronic systolic heart failure].
    Galinier M
    Rev Prat; 2010 Sep; 60(7):941-6. PubMed ID: 21033491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatment for chronic systolic heart failure.
    Mörike K; Sindermann JR
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S170-2. PubMed ID: 20101534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of systolic heart failure in the elderly: an evidence-based review.
    Arif SA; Mergenhagen KA; Del Carpio RO; Ho C
    Ann Pharmacother; 2010 Oct; 44(10):1604-14. PubMed ID: 20841514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
    J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to heart failure and diabetes mellitus.
    Fonarow GC
    Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
    Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
    Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
    Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic heart failure--the epidemic of the 21st century].
    Czuriga I
    Orv Hetil; 2005 May; 146(20 Suppl 2):1075-87. PubMed ID: 15945236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
    Pitt B; Fonarow GC; Gheorghiade M; Deedwania PC; Duprez DA
    Am J Cardiol; 2006 May; 97(10A):26F-33F. PubMed ID: 16698332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 18. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M
    MMW Fortschr Med; 2002 Nov; 144(48):38-43. PubMed ID: 12532542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of advanced chronic heart failure].
    Oliva F; Macera F; Verde A; Frigerio M
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):112S-117S. PubMed ID: 19195318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination therapy with ARB for heart failure].
    Sakata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():123-7. PubMed ID: 17569310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.